DiamondHead Holdings Corp. (NASDAQ:DHHC) announced this morning that it has added convertible note and PIPE financing that is expected to bring up to $155 million in new financing to its combination with Great Southern Homes.
The funding package is to be made up of 744,588 Class A shares purchased through the PIPE for an aggregate gross investment of $75 million and notes purchased at an initial principal amount of $80 million. These notes are to bear a 15% per annum interest rate and mature five years out from close.
Beginning on the first anniversary of the transaction’s closing, the notes are convertible to Class A shares at 80% of their trading price at the time for a maximum share price of $10 and a minimum of $5.
The changes come as DiamondHead rolls into its completion vote for the Great Southern Homes deal tomorrow, March 23. This special meeting was originally scheduled for March 14, but the SPAC rescheduled it likely to engage investors and seek out additional financing pieces like these it has now announced.
The $572 million combination, which the parties announced in September, carries a $125 million minimum cash condition, which would appear to be covered by this new investment.
Diamondhead did not initially include a PIPE in the transaction at announcement and its trust has been reduced to about $44.9 million through redemptions thus far.
Columbia, South Carolina-based Great Southern Homes is one of the largest homebuilders in the Southeast and focuses on the entry level home buyer segments. If approved, the combined company is expected to trade on the Nasdaq under the new ticker symbol “UHG”.
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...
In June 2025, the SPAC market was marked by a notable rise in meeting delays, with adjournments and postponements playing a central role in extension activity, as sponsors navigated a more cautious market environment. Still, several SPACs secured shareholder approvals, and seven business combinations were completed during the month. At the same time, IPO issuance...
An In-Depth Look at SPAC Activity Through the Second Quarter & First Half 2025 Below is a summary of the first half of 2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. Q2 kicked off in chaos. President Trump’s shifting and often contradictory tariff announcements sent markets reeling, driving...
At the SPAC of Dawn The market is set to be showered with new SPACs today as three more SPACs priced their IPOs overnight, bringing 2025’s total to 66, already surpassing the full-year total of 2024. After hours, Ribbon (NASDAQ:RIBB) also added a new SPAC deal to June’s tally just under the wire, bringing the...